# Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis

> **NCT07242612** · NA · RECRUITING · sponsor: **Khyber Medical University Peshawar** · enrollment: 40 (estimated)

## Conditions studied

- Osteoporosis
- Osteoporosis, Postmenopausal

## Interventions

- **DRUG:** Alendronate, Ibandronate; Risedronate
- **DRUG:** Teriparatide

## Key facts

- **NCT ID:** NCT07242612
- **Lead sponsor:** Khyber Medical University Peshawar
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2026-03-25
- **Final completion:** 2026-04-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07242612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07242612, "Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT07242612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*